SCHEMBL5268464

SCHEMBL5268464

COC(=O)C(Br)C1CCNCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 5/20 0.44
SLC6A4 P31645 5/20 0.44
SLC6A3 Q01959 5/20 0.44
CPN1 P15169 1/20 0.38
CPB2 Q96IY4 1/20 0.38
EPHX1 P07099 1/20 0.36
PADI1 Q9ULC6 1/20 0.35
PADI4 Q9UM07 1/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP3 P08254 1/20 0.35
MMP7 P09237 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
TSHR P16473 1/20 0.34
GABRB1 P18505 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15618893 0.86
SCHEMBL31572346 0.82 THRB (0.44) SLC6A3MMP2TSHRTHRBTP53
SCHEMBL2554561 0.82 TP53 (0.47) SLC6A3MMP2TSHRTHRBTP53
SCHEMBL5265181 0.81 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL1605366 0.80 TP53 (0.50) SLC6A3EPHX1MMP2TSHRTHRB
SCHEMBL20740436 0.80 TP53 (0.50) SLC6A3EPHX1MMP2TSHRTHRB
SCHEMBL14218540 0.80 TP53 (0.50) SLC6A3EPHX1MMP2TSHRTHRB
SCHEMBL1037114 0.78 SLC6A3 (0.46) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL18307376 0.78 SLC6A3 (0.46) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL27687987 0.78 CPN1 (0.33) SLC6A2SLC6A4SLC6A3CPN1CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010080873-A1 OXAZOLES AS MODULATORS OF CHEMOKINE RECEPTORS GLAXO GROUP LIMITED (GB) 2010-07-15 WO disclosed
EP-1802602-A1 SUBSTITUTED DIPIPERDINE CCR2 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-04 EP disclosed
WO-2006036527-A1 SUBSTITUTED DIPIPERDINE CCR2 ANTAGONISTS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-04-06 WO disclosed